Qurient Co. Ltd (115180) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.314x

Based on the latest financial reports, Qurient Co. Ltd (115180) has a cash flow conversion efficiency ratio of -0.314x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-10.30 Billion ≈ $-6.98 Million USD) by net assets (₩32.82 Billion ≈ $22.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Qurient Co. Ltd balance sheet quality to measure how much of total assets are equity-financed.

Qurient Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Qurient Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore investment intensity of Qurient Co. Ltd to see how much of total assets are deployed in long-term investments.

Qurient Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qurient Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Anhui Zhongyuan New Materials Co Ltd SHG:603527	-0.130x
Universal Logistics Holdings Inc NASDAQ:ULH	0.045x
Ovzon AB ST:OVZON	0.041x
Hankook Shell Oil KO:002960	0.124x
Jiangsu Huifeng Agrochemical Co Ltd SHE:002496	0.002x
Genesco Inc NYSE:GCO	0.314x
Medistim ASA OL:MEDI	0.098x
Prince Housing & Development Corp TW:2511	0.048x

Annual Cash Flow Conversion Efficiency for Qurient Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Qurient Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see 115180 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩39.19 Billion ≈ $26.56 Million	₩-28.67 Billion ≈ $-19.43 Million	-0.732x	-80.73%
2024-12-31	₩57.60 Billion ≈ $39.03 Million	₩-23.32 Billion ≈ $-15.80 Million	-0.405x	+14.10%
2023-12-31	₩46.62 Billion ≈ $31.59 Million	₩-21.97 Billion ≈ $-14.89 Million	-0.471x	+33.78%
2022-12-31	₩35.14 Billion ≈ $23.81 Million	₩-25.00 Billion ≈ $-16.94 Million	-0.712x	-57.89%
2021-12-31	₩54.08 Billion ≈ $36.65 Million	₩-24.37 Billion ≈ $-16.52 Million	-0.451x	-28.45%
2020-12-31	₩56.57 Billion ≈ $38.33 Million	₩-19.85 Billion ≈ $-13.45 Million	-0.351x	+74.59%
2019-12-31	₩17.38 Billion ≈ $11.78 Million	₩-24.00 Billion ≈ $-16.26 Million	-1.381x	-294.23%
2018-12-31	₩39.41 Billion ≈ $26.70 Million	₩-13.80 Billion ≈ $-9.36 Million	-0.350x	+59.55%
2017-12-31	₩14.53 Billion ≈ $9.85 Million	₩-12.59 Billion ≈ $-8.53 Million	-0.866x	-113.10%
2016-12-31	₩24.35 Billion ≈ $16.50 Million	₩-9.90 Billion ≈ $-6.71 Million	-0.406x	+84.40%
2015-12-31	₩2.89 Billion ≈ $1.96 Million	₩-7.54 Billion ≈ $-5.11 Million	-2.605x	-950.52%
2014-12-31	₩-21.68 Billion ≈ $-14.69 Million	₩-6.64 Billion ≈ $-4.50 Million	0.306x	--

About Qurient Co. Ltd

KQ:115180 Korea Biotechnology

Market Cap

$434.60 Million

₩641.30 Billion KRW

Market Cap Rank

#12827 Global

#343 in Korea

Share Price

₩17210.00

Change (1 day)

+3.30%

52-Week Range

₩10000.00 - ₩50900.00

All Time High

₩50900.00